In 2010, Genovese et al. described that the focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage renal disease (ESRD) are associated with two independent sequence variants in the APOL1 [2] among African American individuals. The gene discussed is APOL1; the disease is focal segmental glomerulosclerosis.